Pacific Capital Partners’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.51M | Sell |
97,500
-77,500
| -44% | -$2.79M | 3.29% | 12 |
|
|
2025
Q1 | $5.45M | Buy |
175,000
+12,500
| +8% | +$389K | 3.45% | 12 |
|
|
2024
Q4 | $4.15M | Hold |
162,500
| – | – | 2.44% | 16 |
|
|
2024
Q3 | $4.6M | Hold |
162,500
| – | – | 2.69% | 13 |
|
|
2024
Q2 | $4.29M | Hold |
162,500
| – | – | 2.84% | 12 |
|
|
2024
Q1 | $4.94M | Buy |
162,500
+12,500
| +8% | +$380K | 3.23% | 11 |
|
|
2023
Q4 | $4.21M | Sell |
150,000
-21,500
| -13% | -$604K | 3.18% | 11 |
|
|
2023
Q3 | $4.65M | Buy |
+171,500
| New | +$4.65M | 2.81% | 13 |
|